This program was supported through an independent medical education grant from Dexcom Medical Affairs. Experts discuss the key benefits of continuous glucose monitoring (CGM) technology compared with traditional monitoring based on recent clinical trial data, including research on cardiovascular risk reduction in noninsulin-treated T2D.
Video content above is prompted by the following:
Based on recent clinical trial data, including your research on cardiovascular-risk reduction in noninsulin patients, what are the key benefits of CGM technology compared with traditional monitoring?
New Blueprint Guides Patient-Centered Research for More Equitable Health Care
July 17th 2025The new Blueprint for Patient-Centered Value Research offers a roadmap for embedding patient voices throughout every stage of the research journey to foster more equitable, transparent, and responsive health care systems.
Read More